Helicon Therapeutics
San Diego
About Helicon Therapeutics
Helicon Therapeutics discovers therapeutics to treat disorders of cognition through genetic basis of long-term memory formation.
Company Facts
- Total funding: $108.8M
- Funding stage: Late Stage Venture
- Last round: Series F (Sep 2009)
Canonical: https://fsome.com/organization/helicon-therapeutics-8309358 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.